O‐GlcNAcylation modulates several pathways implicated in AD pathogenesis, including the processing of APP, tau phosphorylation, synaptic integrity, and insulin signaling.179, 180, 181, 182, 183. This evidence concerns the gene MAPT and Alzheimer disease.